Trevi Therapeutics Inc
Ownership
Ownership Structure
Who owns Trevi Therapeutics Inc (TRVI)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 83.0% of the shares are freely tradable; institutional investors hold 98.3%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| NEA Management Company, LLC | 9.28 | 13,222,228 | +0.0 | 06/30/2026 |
| FMR Inc | 8.82 | 12,562,839 | +56.3 | 06/30/2026 |
| BlackRock Inc | 7.83 | 11,155,026 | +8.9 | 06/30/2026 |
| Frazier Life Sciences Management, L.P. | 6.98 | 9,939,447 | +0.0 | 06/30/2026 |
| Wellington Management Company LLP | 3.99 | 5,684,592 | +9.5 | 06/30/2026 |
| Vanguard Capital Management, LLC | 3.88 | 5,530,675 | +11.1 | 06/30/2026 |
| Vivo Capital, LLC | 3.58 | 5,094,668 | +0.0 | 06/30/2026 |
| Woodline Partners LP | 2.86 | 4,081,333 | +307.8 | 06/30/2026 |
| Vestal Point Capital LP | 2.18 | 3,100,000 | +43.1 | 06/30/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard MStar Total Stk Mkt Idx Invest | 3.23 | 4,606,695 | +13.5 | 09/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Heffernan Michael Thomas | Director | 6,451 | 87,734 $ | Sep 15, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 15, 2026 | Heffernan Michael Thomas | Director | Sell | 20,952 | 15.09 | 316,166 |
| Sep 15, 2026 | Heffernan Michael Thomas | Director | Other | 21,052 | 3.33 | 70,103 |
| Sep 15, 2026 | Heffernan Michael Thomas | Director | Sell | 100 | 15.88 | 1,588 |
| Sep 15, 2026 | Heffernan Michael Thomas | Director | Sell | 18,321 | 15.09 | 276,464 |
| Sep 15, 2026 | Heffernan Michael Thomas | Director | Other | 18,421 | 3.04 | 56,000 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: November 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.